Our Pipeline

Aura is developing a pipeline of virus-like drug conjugate, or VDC, therapeutic candidates for high unmet need cancers that either have no approved drugs available or are poorly managed with currently available treatments.

Aura Pipeline November 6 2023

Learn more about Aura’s Expanded Access Policy

Click here

Meet the Team
Meet the Team
Aura has assembled a world-class leadership team.
Choroidal Melanoma
Choroidal Melanoma
Our lead VDC Bel-sar is about to enter late-stage clinical trials.
Ocular Oncology
Ocular Oncology
Ocular cancers are a group of rare, life-threatening conditions that affect the eyes.